Easton Pharmaceuticals Signs LOI to Acquire a Cosmetic Anti-Aging and Beauty Care Line of Products Including a Product to Compliment its Medical Marijuana Initiatives

Published: Sep 27, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TORONTO--(BUSINESS WIRE)--Easton Pharmaceuticals, Inc. (OTC: EAPH) a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products, today announces it has signed a letter of intent to acquire a line of Anti-Ageing and beauty care products.

Help employers find you! Check out all the jobs and post your resume.

Back to news